Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Mardepodect

Catalog No. T16499Cas No. 898562-94-2
Alias PF-2545920

Mardepodect (PF-2545920) is a phosphodiesterase inhibitor selective for the PDE10A subtype with an IC50 of 0.37 nM and over 1000-fold selectivity over PDE. It is potentially useful for the treatment of schizophrenia. Phosphodiesterase 10A (PDE10A) is highly expressed in striatal medium spiny neurons of both the direct and indirect output pathways. Mardepodect can cross the blood-brain barrier.

Mardepodect

Mardepodect

Purity: 99.81%
Catalog No. T16499Alias PF-2545920Cas No. 898562-94-2
Mardepodect (PF-2545920) is a phosphodiesterase inhibitor selective for the PDE10A subtype with an IC50 of 0.37 nM and over 1000-fold selectivity over PDE. It is potentially useful for the treatment of schizophrenia. Phosphodiesterase 10A (PDE10A) is highly expressed in striatal medium spiny neurons of both the direct and indirect output pathways. Mardepodect can cross the blood-brain barrier.
Pack SizePriceAvailabilityQuantity
1 mg$36In Stock
2 mg$50In Stock
5 mg$84In Stock
10 mg$153In Stock
25 mg$258In Stock
50 mg$385In Stock
100 mg$576In Stock
1 mL x 10 mM (in DMSO)$93In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Mardepodect"

Select Batch
Purity:99.81%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Mardepodect (PF-2545920) is a phosphodiesterase inhibitor selective for the PDE10A subtype with an IC50 of 0.37 nM and over 1000-fold selectivity over PDE. It is potentially useful for the treatment of schizophrenia. Phosphodiesterase 10A (PDE10A) is highly expressed in striatal medium spiny neurons of both the direct and indirect output pathways. Mardepodect can cross the blood-brain barrier.
Targets&IC50
PDE10A:0.37 nM
In vivo
Mardepodect is active in a range of antipsychotic models with the ED50 of 1 mg/kg, antagonizing apomorphine-induced climbing in mice, inhibiting conditioned avoidance responding in both rats and mice, and blocking N-methyl-D-aspartate antagonist-induced deficits in prepulse inhibition of acoustic startle response in rats, while improving baseline sensory gating in mice.Mardepodect induces a dose-dependent increase in striatal cGMP in mice.
AliasPF-2545920
Chemical Properties
Molecular Weight392.45
FormulaC25H20N4O
Cas No.898562-94-2
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 45 mg/mL (114.66 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.5481 mL12.7405 mL25.4810 mL127.4048 mL
5 mM0.5096 mL2.5481 mL5.0962 mL25.4810 mL
10 mM0.2548 mL1.2740 mL2.5481 mL12.7405 mL
20 mM0.1274 mL0.6370 mL1.2740 mL6.3702 mL
50 mM0.0510 mL0.2548 mL0.5096 mL2.5481 mL
100 mM0.0255 mL0.1274 mL0.2548 mL1.2740 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Mardepodect | purchase Mardepodect | Mardepodect cost | order Mardepodect | Mardepodect chemical structure | Mardepodect in vivo | Mardepodect formula | Mardepodect molecular weight